Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats

Hepatology

Volumn 36, Issue 4I, 2002, Pages 840-849

  Moal, Frédéric ^a   Chappard, Daniel ^a   Wang, Jianhua ^a   Vuillemin, Eric ^a   Michalak Provost, Sophie ^a   Rousselet, Marie Christine ^a   Oberti, Frédéric ^a   Calès, Paul ^a  

^a UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 O VINYL 1 (PYRROLIDIN 1 YL)DIAZEN 1 IUM 1,2 DIOLATE; CARBON TETRACHLORIDE; FIBRONECTIN; HYALURONIC ACID; HYDROXYPROLINE; MESSENGER RNA; OCTREOTIDE; PLACEBO; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DISEASE MODEL; FEASIBILITY STUDY; FRACTAL ANALYSIS; HISTOLOGY; IMAGE ANALYSIS; LIVER FIBROSIS; LIVER LEVEL; MALE; MEASUREMENT; MORPHOMETRICS; NONHUMAN; OBSERVER VARIATION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY;

ANIMALS; BILE DUCTS; CARBON TETRACHLORIDE POISONING; DISEASE MODELS, ANIMAL; FRACTALS; GASTROINTESTINAL AGENTS; LIGATION; LIVER CIRRHOSIS; MALE; MODELS, BIOLOGICAL; OCTREOTIDE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS;

EID: 0036789335     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.35533     Document Type: Article

References (47)

1. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aubé C, Gallois Y, et al. Noninvasive diagnostic of hepatic fibrosis or cirrhosis. Gastroenterology 1997;113:1609-1616.
2. Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WHJ. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Dig Dis 1971;16:1082-1086.
3. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
4. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.
5. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
6. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle biopsy specimens: comparison with morphometric studies. Hepatology 1994;20:349-355.
7. Rubio CA, Porwitt A. Quantitation of fibrosis in liver biopsies. Anal Quant Cytol Histol 1988;10:107-109.
8. Feldmann G. Critical analysis of the methods used to morphologically quantify hepatic fibrosis. J Hepatol 1995;22 (Suppl 2):49-54.
9. James J, Bosch KS, Aronson DC, Houtkooper JM. Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver. Liver 1990;10:1-5.
10. Pilette C, Rousselet M, Bedossa P, Chappard D, Oberti F, Rifflet H, Maiga MY, et al. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores: comparison with serum markers. J Hepatol 1998;28:439-446.
11. Cross SS. The application of fractal geometric analysis to microscopic images. Micron 1994;25:101-113.
12. Cross SS. Fractals in pathology. J Pathol 1997;182:1-8.
13. Peitgen HO, Saupe D. The Science of Fractal Images, New York: SpringerVerlag, 1988.
14. Mandelbrot BB. The Fractal Geometry of Nature. New York: W.H. Freeman, 1982.
15. Russ JC. Fractal Surfaces. New York: Plenum, 1994.
16. Fort J, Oberti F, Pilette C, Veal N, Gallois Y, Douay O, Rousselet MC, et al. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Hepatology 1998;28:1525-1531.
17. Oberti F, Pilette C, Rifflet H, Maiga M, Moreau A, Gallois Y, Girault A, et al. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol 1997;26:1363-1371.
18. Lebrec D. Animal models of portal hypertension. In: Okuda K, Benhamou JP, eds. Portal Hypertension: Clinical and Physiological Aspects. Tokyo: Springer-Verlag, 1991:101-113.
19. Proctor E, Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology 1982;83:1183-1190.
20. Fiorucci S, Antonelli E, Morelli O, Mencarelli A, Casini A, Mello T, Palazzetti B, et al. NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Nad Acad Sci U S A 2001;98:8897-8902.
21. Saavedra JE, Billiar TR, Williams DL, Kim YM, Watkins SC, Keefer LK. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-α-induced apoptosis and toxicity in the liver. J Med Chem 1997;40:1947-1954.
22. Jamall IS, Finelli Vn, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 1981;112:70-75.
23. Chomczinski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
24. Puissant C, Houdebine I-M. An improvement of the single-step method of RNA isolation by acid guanidium-phenol-chloroform extraction. Biotechniques 1990,8:148-149.
25. Scharzbauer JE, Tamkun JW, Lemischka IR, Hynes RO. Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 1983;35:421-431.
26. Selden C, Farnaud S, Ding SF, Habib N, Foster C, Hodgson H. Expression of hepatocyte growth factor mRNA, and c-met mRNA (hepatocyte growth factor receptor) in human liver turnouts. J Hepatol 1994;21:227-234.
27. Losa G, Nonnenmacher TF. Self-similarity and fractal irregularity in pathologic tissues. Mod Pathol 1995;9:174-182.
28. Chappard D, Legrand E, Pascaretti C, Audran M, Baslé MF. Comparison of eight histomophometric methods for measuring trabecular bone architecture by image analysis on histological sections. Microsc Res Tech 1999;45:303-312.
29. Smith TGJ, Lange GD, Marks WB. Fractal methods and results in cellular motphology-dimensions, lacunarity and multifractals. J Neurosci Methods 1996;182:123-136.
30. Kaye BH. Discovering texture fractals. In: Kaye BH, ed. A Random Walk Through Fractal Dimensions. Weinheim, Germany: VCH, 1989:20-25.
31. Weibel ER. Fractal geometry: a design principle for living organisms. Am J Physiol 1991;261:L361-L369.
32. Jelinek HF, Fernandez E. Neurons and fractals: how reliable and useful are calculations of fractal dimension? J Neurosci Methods 1998;81:9-18.
33. Smith TGJ, Lange GD. Biological cellular morphometry-fractal dimensions, lacunarity and multifractals. In: Losa GA, Merlini D, Nonnenmacher TF, Weibel ER, eds. Fractals in Biology and Medicine,. Volume 2. Basel: Birkhäuser, 1997:30-49.
34. DeMeester SL, Cobb JP, Hotchkiss RS, Osborne DF, Karl IE, Tinsley KW, Buchman TG. Stress-induced fractal rearrangement of the endothelial cell cytoskeleton causes apoptosis. Surgery 1998;124:362-371.
35. Fielding A. Applications of fractal geometry to biology. Comput Appl Biosci 1992;8:359-366.
36. Sanders H, Crocker J. A simple technique for the measurement of fractal dimensions in histopathological specimens. J Pathol 1993;169:383-385.
37. Keough KMW, Hyam P, Pink DA, Quinn B. Cell surfaces and fractal dimensions. J Microsc 1991;163:95-99.
38. Chappard D, Legrand E, Haettich B, Chales G, Auvinet B, Eschard JP, Hamelin JP, et al. Fractal dimension of trabecular bone: comparison of 3 histomorphometric computed techniques for measuring the architectural two-dimensional complexity. J Pathol 2001;195:515-521.
39. Kikuchi T, Nakazawa T, Fukukawa T, Higuchi T, Maruyama Y, Sato S. Quantitative estimation of the amount of fibrosis in the rat liver using fractal dimension of the shape of power spectrum. Jpn J Appl Physiol 1995;34:2831-2834.
40. Dioguardi N, Grizzi F, Bossi P, Roncalli M. Fractal and spectral dimension analysis of liver fibrosis in needle biopsy specimens. Anal Quant Cytol Histol 1999;21:262-266.
41. James J, Bosch KS, Zuydethout FMJ, Van Gool J. Histomorphometric estimation of volume density of collagen as an indication of fibrosis in rat liver. Histochemistry 1986;85:129-133.
42. Junquiera LCU, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979;11:447-455.
43. Puchtler H, Meloan SN, Waldrop FS. Are picro-dye reactions for collagens quantitative? Chemical and histochemical considerations. Histochemistry 1988;88:243-256.
44. Landini G, Rippin JW. Fractal dimensions of the epithelial-connective tissue interfaces in premalignant and malignant epithelial lesions of the floor of the mouth. Anal Quant Cytol Histol 1993;15:144-149.
45. Sabo E, Boltenko A, Sova Y, Stein A, Kleinhaus S, Resnick MB. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 2001;7:533-537.
46. Libouban H, Moreau MF, Legrand E, Audran M, Baslé MF, Chappard D. Comparison of histomorphometric descriptors of bone architecture with dual-energy x-ray absorptiometry for assessing bone loss in the orchidectomized rat. Osteoporos Int 2002;13:422-428.
47. Chappard D, Chennebault A, Moreau MF, Legrand E, Audran M, Basle MF. Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin. Bone 2001;28:72-79.